NeuroOne Medical Technologies Corporation

NMTC ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-47.8K $-62.9K $-36.2K $-30.6K $-14.0K $-27.6K $-6.0K
Depreciation & Amortization — — — — — — —
Depreciation — — — — — — —
Amortization — — — — — — —
Stock-Based Compensation — — — — — — —
Net Cash from Operating Activities $-21.1K $-30.2K $-26.2K $-25.1K $-13.7K $-27.4K $-5.1K
Investing Activities
Capital Expenditures — — — — — — —
Business Acquisitions — — — — — — —
Net Cash from Investing Activities — — — — $0 $0 —
Financing Activities
Dividends Paid — — — — — — —
Stock Repurchases — — — — — — —
Net Cash from Financing Activities — — — — $1.0K $32.2K $13.0K
Net Change in Cash — — — — — — —
Free Cash Flow — — — — — — —
← Newer Page 2 of 2 Older →